Citadel Advisors’s Principal Exchange-Traded Funds Principal Healthcare Innovators ETF BTEC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-19,556
| Closed | -$713K | – | 15639 |
|
|
2024
Q2 | $713K | Buy |
19,556
+12,143
| +164% | +$438K | ﹤0.01% | 7325 |
|
|
2024
Q1 | $282K | Sell |
7,413
-41
| -0.6% | -$1.52K | ﹤0.01% | 9588 |
|
|
2023
Q4 | $271K | Sell |
7,454
-2,737
| -27% | -$81.7K | ﹤0.01% | 9351 |
|
|
2023
Q3 | $307K | Sell |
10,191
-2,999
| -23% | -$101K | ﹤0.01% | 9120 |
|
|
2023
Q2 | $474K | Buy |
+13,190
| New | +$472K | ﹤0.01% | 8064 |
|
|
2023
Q1 | – | Sell |
-15,309
| Closed | -$515K | – | 15737 |
|
|
2022
Q4 | $515K | Sell |
15,309
-15,943
| -51% | -$538K | ﹤0.01% | 8180 |
|
|
2022
Q3 | $1.07M | Buy |
+31,252
| New | +$1.14M | ﹤0.01% | 6849 |
|
|
2022
Q2 | – | Sell |
-9,307
| Closed | -$369K | – | 14406 |
|
|
2022
Q1 | $369K | Sell |
9,307
-5,287
| -36% | -$209K | ﹤0.01% | 10116 |
|
|
2021
Q4 | $690K | Buy |
14,594
+10,579
| +263% | +$545K | ﹤0.01% | 8879 |
|
|
2021
Q3 | $219K | Buy |
+4,015
| New | +$227K | ﹤0.01% | 11805 |
|
|
2021
Q2 | – | Sell |
-32,042
| Closed | -$1.84M | – | 14621 |
|
|
2021
Q1 | $1.84M | Buy |
32,042
+302
| +1% | +$18.9K | ﹤0.01% | 6588 |
|
|
2020
Q4 | $1.86M | Buy |
+31,740
| New | +$1.71M | ﹤0.01% | 5487 |
|
|
2020
Q3 | – | Sell |
-12,698
| Closed | -$567K | – | 10907 |
|
|
2020
Q2 | $567K | Sell |
12,698
-7,762
| -38% | -$310K | ﹤0.01% | 6853 |
|
|
2020
Q1 | $643K | Buy |
20,460
+802
| +4% | +$29.3K | ﹤0.01% | 6072 |
|
|
2019
Q4 | $758K | Sell |
19,658
-821
| -4% | -$28.8K | ﹤0.01% | 6104 |
|
|
2019
Q3 | $633K | Sell |
20,479
-27,467
| -57% | -$911K | ﹤0.01% | 6347 |
|
|
2019
Q2 | $1.63M | Buy |
47,946
+31,780
| +197% | +$1.05M | ﹤0.01% | 4868 |
|
|
2019
Q1 | $558K | Buy |
+16,166
| New | +$537K | ﹤0.01% | 6617 |
|
Citadel Advisors's BTEC Position: Q3 2024 in Review
Citadel Advisors sold out of Principal Exchange-Traded Funds Principal Healthcare Innovators ETF (BTEC) in Q3 2024, closing a stake of 19,556 shares — an estimated $713K sold.
Citadel Advisors first reported a position in BTEC in Q1 2019 and held it in 18 quarters. The position peaked at $1.86M in Q4 2020. 0 funds tracked by Wall St. Rank hold BTEC as of Q3 2024.
- Citadel Advisors reported no remaining Principal Exchange-Traded Funds Principal Healthcare Innovators ETF position as of Q3 2024 after selling out during the quarter.
- Citadel Advisors sold 19,556 Principal Exchange-Traded Funds Principal Healthcare Innovators ETF shares in Q3 2024, an estimated $713K.
- Citadel Advisors first reported a position in Principal Exchange-Traded Funds Principal Healthcare Innovators ETF in Q1 2019 and held it in 18 quarters.
- Citadel Advisors's Principal Exchange-Traded Funds Principal Healthcare Innovators ETF position peaked at $1.86M in Q4 2020.
- 0 funds tracked by Wall St. Rank held Principal Exchange-Traded Funds Principal Healthcare Innovators ETF as of Q3 2024.
Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.